KDYWIQBIAXIWDN-UHFFFAOYSA-N
C26H26F3N5O2S — CID 118168006
Data last refreshed: (MolForge compound catalog, from PubChem)
About KDYWIQBIAXIWDN-UHFFFAOYSA-N
KDYWIQBIAXIWDN-UHFFFAOYSA-N (PubChem CID 118168006) has the molecular formula C26H26F3N5O2S and a molecular weight of 529.59 g/mol. Its IUPAC name is N-[(6-methyl-1-oxidopyridin-1-ium-3-yl)methyl]-3-(5-methylthiophen-2-yl)-8-[4-(trifluoromethyl)piperidin-1-yl]imidazo[1,2-a]pyridine-6-carboxamide.
Molecular Properties
| Compound Name | KDYWIQBIAXIWDN-UHFFFAOYSA-N |
|---|---|
| PubChem CID | 118168006 |
| Molecular Formula | C26H26F3N5O2S |
| Molecular Weight | 529.59 g/mol |
| Exact Mass | 529.18 |
| IUPAC Name | N-[(6-methyl-1-oxidopyridin-1-ium-3-yl)methyl]-3-(5-methylthiophen-2-yl)-8-[4-(trifluoromethyl)piperidin-1-yl]imidazo[1,2-a]pyridine-6-carboxamide |
| SMILES | Cc1ccc(-c2cnc3c(N4CCC(C(F)(F)F)CC4)cc(C(=O)NCc4ccc(C)[n+]([O-])c4)cn23)s1 |
| InChI | InChI=1S/C26H26F3N5O2S/c1-16-3-5-18(14-34(16)36)12-31-25(35)19-11-21(32-9-7-20(8-10-32)26(27,28)29)24-30-13-22(33(24)15-19)23-6-4-17(2)37-23/h3-6,11,13-15,20H,7-10,12H2,1-2H3,(H,31,35) |
| InChIKey | KDYWIQBIAXIWDN-UHFFFAOYSA-N |
| XLogP | 5.02 |
| TPSA | 76.58 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 37 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 529.59 |
| LogP ≤ 5 | 5.02 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'N_oxide', 'substructure': 'N/A'}, {'alert_name': 'quaternary_nitrogen_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118168006 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.